Engaging communities in tuberculosis research

The Lancet Infectious Diseases

Volumn 13, Issue 6, 2013, Pages 540-545

  Boulanger, Renaud F ^a   Seidel, Stephanie ^c   Lessem, Erica ^d   Pyne Mercier, Lee ^e,f   Williams, Sharon D ^g   Mingote, Laia Ruiz ^h   Scott, Cherise ^c,i   Chou, Alicia Y ^j   Lavery, James V ^a,b,k  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c Global Alliance for TB Drug Development   (United States)

^d Treatment Action Group   (United States)

^e BILL AND MELINDA GATES FOUNDATION   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^h Planeta Salud   (Spain)

ⁱ Stop TB Partnership   (United States)

^j CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^k UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

CLINICAL TRIAL (TOPIC); COMMUNITY CARE; COMMUNITY PROGRAM; CONCEPTUAL FRAMEWORK; HEALTH CARE SYSTEM; HEALTH EDUCATION; HUMAN; MEDICAL RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESOURCE ALLOCATION; REVIEW; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; BIOMEDICAL RESEARCH; CLINICAL TRIALS AS TOPIC; COMMUNITY-BASED PARTICIPATORY RESEARCH; CONSENSUS; COOPERATIVE BEHAVIOR; HUMANS; TUBERCULOSIS;

EID: 84878435860     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70042-2     Document Type: Review

References (43)

1. Los Angeles Times (LA), April 24, 1993 WHO calls tuberculosis a global emergency, (accessed March 8, 2013). http://articles.latimes.com/1993-04-24/news/mn-26683_1_global-emergency.
2. Clayden P, Collins S, Daniels C, et al. 2012 pipeline report: HIV, HCV, TB-drugs, diagnostics, vaccines, and preventive technologies in development 2012, for HIV i-base and Treatment Action Group, Treatment Action Group, New York, NY.
3. Principles of community engagement 2011, Clinical and Translational Science Awards Consortium Community Engagement Key Function Committee Task Force on the Principles of Community Engagement, National Institutes of Health, Atlanta, GA. 2nd edn.
4. Tindana PO, Singh JA, Tracy CS, et al. Grand challenges in global health: community engagement in research in developing countries. PLoS Med 2007, 4:e273.
5. MacQueen KM, McLellan E, Metzger DS, et al. What is community? An evidence-based definition for participatory public health. Am J Public Health 2001, 91:1929-1937.
6. Morin SF, Morfit S, Maiorana A, et al. Building community partnerships: case studies of community advisory boards at research sites in Peru, Zimbabwe, and Thailand. Clin Trials 2008, 5:147-156.
7. Rerks-Ngram S, Pitisuttithum P, Nitayaphan S, et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009, 361:2209-2220.
8. AVAC report 2010: turning the page 2010, AVAC, AVAC, New York, NY.
9. Shin S, Furin J, Bayona J, Mate K, Kim JY, Farmer P Community-based treatment of multidrug-resistant tuberculosis in Lima, Peru: 7 years of experience. Soc Sci Med 2004, 59:1529-1539.
10. Kelkar-Khambete A, Kielmann K, Pawar S, et al. India's revised national tuberculosis control programme: looking beyond detection and cure. Int J Tuberc Lung Dis 2008, 12:87-92.
11. The global plan to stop TB 2006-2015: actions for life, towards a world free of tuberculosis 2006, WHO, World Health Organization, Geneva, Switzerland.
12. Community involvement in tuberculosis care and prevention 2008, WHO, World Health Organization, Geneva, Switzerland.
13. Challenge facility for civil society Stop TB Partnership, (accessed Nov 1, 2012). http://www.stoptb.org/global/awards/cfcs/.
14. Akugizibwe P, Ramakant B Challenges for community role in tuberculosis response. Lancet 2010, 375:2059-2061.
15. Mamotte N, Wassenaar D, Koen J, Essack Z Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa. BMC Med Ethics 2010, 11:3.
16. Grant AD, Coetzee L, Fielding KL, et al. " Team up against TB" : promoting involvement in Thibela TB, a trial of community-wide tuberculosis preventive therapy. AIDS 2010, 24(suppl 5):S37-S44.
17. Ntshanga SP, Ngcobo PS, Mabaso MLH Establishment of a community advisory board (CAB) for tuberculosis control and research in the Inanda, Ntuzuma and KwaMashu (INK) area of KwaZulu-Natal, South Africa. Health Policy 2010, 95:211-215.
18. Check E After decades of drought, new drug possibilities flood TB pipeline. Nat Med 2007, 13:266.
19. Cox LE, Rouff JR, Svendsen KH, Markowitz M, Abrams DI Community advisory boards: their role in AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS. Health Soc Work 1998, 23:290-297.
20. Recommendations for community involvement in National Institute of Allergy and Infectious Diseases HIV/AIDS clinical trials research, February, 2009 NIAID Community Recommendations Working Group of Community Partners, (accessed Nov 1, 2012). http://www.niaid.nih.gov/about/organization/daids/Networks/Documents/cabrecommendations.pdf.
21. Prevention now! About the HPTN HIV Prevention Trials Network, (accessed Nov 1, 2012). http://www.hptn.org/AboutHPTN.htm.
22. Community involvement in international research: lessons learned from the HIV Prevention Trials Network 2006, Family Health International, Family Health International, Research Triangle Park, NC.
23. Epstein S The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials. Sci Technol Human Values 1995, 20:408-437.
24. Wachter R AIDS, activism and the politics of health. N Engl J Med 1992, 326:128-133.
25. Harrington M From HIV to tuberculosis and back again: a tale of activism in 2 pandemics. Clin Infect Dis 2010, 1550(suppl 3):S260-S266.
26. Koen J, Essack Z, Slack C, Lindegger G, Newman PA 'It looks like you just want them when things get rough': civil society perspectives on negative trial results and stakeholder engagement in HIV prevention trials. Dev World Bioeth 2012, published online Sep 24. 10.1111/j.1471-8847.2012.00338.x.
27. Preventing prevention trial failures: a case study and lessons for future trials from the 2004 tenofovir trial in Cambodia 2009, Global Campaign for Microbicides, Global Campaign for Microbicides at PATH, Washington, DC.
28. McGrory E, Irvin A, Heise L Research Rashomon: lessons from the Cameroon pre-exposure prophylaxis trial site 2009, Global Campaign for Microbicides at PATH, Washington, DC.
29. Good participatory practice guidelines for biomedical HIV prevention trials 2007, UNAIDS/AVAC, Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva. 1st edn.
30. Ethical considerations in biomedical HIV prevention trials 2007, UNAIDS, WHOWHO, Joint United Programme on HIV/AIDS, Geneva.
31. Newman P Integrating social and biomedical science in HIV vaccine research: obstacles, opportunities and ways forward. Expert Rev Vaccines 2012, 11:1-3.
32. Kennel M, Woolley J Bridging the gap: engaging researchers and advocates to build support for TB vaccine research and development. Tuberculosis (Edinb) 2012, 92(suppl 1):S30-S32.
33. DeRiemer K, García-García L, Bobadilla-del-Valle M, et al. Does DOTS work in populations with drug-resistant tuberculosis?. Lancet 2005, 365:1239-1245.
34. The Tuberculosis Trials Consortium: a model for clinical trials collaborations. Public Health Rep 2001, 116(suppl 1):41-49. TB Trials Consortium.
35. TB Alliance: Working with constituencies: community engagement program (accessed Nov 1, 2012). http://new.tballiance.org/aaa/endemic.php.
36. Advocacy South African Tuberculosis Vaccine Initiative, (accessed Nov 1, 2012). http://www.satvi.uct.ac.za/index.php/pdf/20101210247/Advocacy.pdf.
37. KEMRI/CDC overview KEMRI/CDC Research and Public Health Collaboration, (accessed Nov 1, 2012). http://www.cdckemri.org/index.php?option=com_content&view=article&id=95&Itemid=53.
38. Global community advisory board AIDS Clinical Trials Group Network, (accessed Nov 1, 2012). https://actgnetwork.org/committees/resource/global-community-advisory-board-overview.
39. About us Stop TB Partnership, (accessed Nov 1, 2012). http://www.stoptb.org/about/.
40. Global TB community advisory board advocacy campaigns Treatment Action Group, (accessed Nov 1, 2012). http://www.treatmentactiongroup.org/tb/advocacy/2012/global-tb-community-advisory-board-advocacy-campaigns.
41. Community engagement and tuberculosis drug research: a 2011 mapping exercise Stakeholder and Community Engagement Workgroup of the Critical Path to TB Drug Regimens, (accessed Sept 17, 2012). http://cptrinitiative.org/wp-content/uploads/2012/02/CEWG-TB-Mapping-exercise.pdf.
42. Lavery JV, Tindana PO, Scott TW, et al. Towards a framework for community engagement in global health research. Trends Parasitol 2010, 26:279-283.
43. Good participatory practice guidelines for TB drug trials, October, 2012 Stakeholder and Community Engagement Workgroup of the Critical Path to TB Drug Regimens, (accessed Nov 1, 2012). http://cptrinitiative.org/downloads/resources/GPP-TB%20Oct1%202012%20FINAL.pdf.